Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Josephine Cucchiaro, PhD
JCP
Original Research
Lurasidone in Early Nonresponding Schizophrenia
December 28, 2016
What's the next step when a patient doesn' t respond to an antipsychotic? Should you augment, switch medications, wait and see, or raise the dose? Read this study in...
Antony Loebel
,
Robert Silva
,
Robert Goldman
, et al
JCP
Original Research
Lurasidone in Older Adults With Bipolar Depression
October 26, 2016
Lurasidone's favorable safety profile in younger adults suggests it would be a good candidate for the treatment of episodes of bipolar depression in older adults. For your patients 55...
Martha Sajatovic
,
Brent P. Forester
,
Joyce Tsai
, et al
JCP
Original Research
Lurasidone and Bipolar Depression
April 22, 2015
Read the analysis of a randomized placebo-controlled trial of Lurasidone in the Treatment of Bipolar Depression With Mixed (Subsyndromal Hypomanic) Features.
Roger S. McIntyre
,
Josephine Cucchiaro
,
Andrei Pikalov
, et al
JCP
Original Research
Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo: A 6-Month, Open-Label, Extension Study
March 13, 2013
Stephen M. Stahl
,
Josephine Cucchiaro
,
Doreen Simonelli
, et al
JCP
Original Research
Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics: A Randomized, 6-Week, Open-Label Study
January 15, 2013
Joseph P. McEvoy
,
Leslie Citrome
,
David Hernandez
, et al
JCP
Original Research
Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial
June 2, 2009
Mitsutaka Nakamura
,
Masaaki Ogasa
,
John Guarino
, et al